Biocapital Europe 2007 - 28th March 2007 - The Krasnapolsky Hotel, Amsterdam, The Netherlands
           
Register today The Benelux Biotechnology Investment Conference
 
  Conference Overview
  Conference Programme
  Presenting Company Profiles
  Speaker Profiles
  Venue Information
  Register Here
  Sponsors
   
  Event organised by:
 
LSP

 
 
Gold Sponsors:
 
 
 
Delegate Book Sponsor:
 
 
Buffet Lunch Sponsor:
 
 
Tea/Coffee Sponsor:
 
 
 
Drinks reception Sponsor:
 
 
Supporter of BioCapitalEurope:
 

REGISTER FOR THE APRIL 2009 EVENT TODAY!

Organised by LSP (Life Sciences Partners) and MeesPierson Corporate Finance & Capital Markets companies, BioCapital Europe is now in its 7th successful consecutive year and has established itself as a platform allowing the most promising and emerging biotech companies from the Benelux as well as a selection of quality biotech companies from other European countries to present to an audience of dedicated biotech VCs and institutional investors.

BioCapital Europe has become a showcase for the industry's progress in these regions, attracting up to 200 high quality delegates (mainly CEO, CFO, pharma execs, VC, and Institutional Investors).

The conference will be held on 21st April 2009. VCs and Institutional Investors are invited to attend free of charge to this event.

LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing to private and public life-science companies. Since the late 1980s, LSP's management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. For example, LSP was a founding investor in Crucell, DNage, Qiagen, Rhein Biotech and Pharming. With over EUR 500 million under management and offices in Amsterdam, Munich and Boston, LSP is one of Europe's largest and most experienced specialist life-science investors. For more information about the LSP Group, please visit the website www.lspvc.com.

The dedicated healthcare team of MeesPierson Corporate Finance & Capital Markets, based in Amsterdam and Frankfurt, has an established track record of successfully completed equity capital markets and M&A transactions. Its pan-European healthcare corporate finance franchise is focused on a wide variety of segments, including biotechnology, (specialty) pharma, life sciences, medical equipment and devices, and healthcare services. As one of the oldest European merchant banks, we value the tradition of building long-term, personalized relationships with our clients.

MeesPierson Corporate Finance & Capital Markets is part of Fortis Bank Nederland (Holding) N.V., which is the holding company in the Netherlands for a variety of businesses providing (inter)national banking and financial services and is present in over 20 countries. Fortis Bank Nederland offers a comprehensive package of products and services to private, corporate and institutional clients. The broad services vary from consumer finance and credit cards to factoring, trust, corporate, energy, commodities and shipping finance, transaction banking, clearing, custody and fund services, investment banking and financial markets services.

Click here to register for the event


 

 
  ©Copyright 2009 BioCapital Europe